China Pharma Holdings Prices $5 Million Stock Offering

China Pharma Holdings Inc. has announced the pricing of a registered direct offering for 2.5 million shares at $2.00 each, aiming to raise $5 million in gross proceeds. The funds, expected to be available around July 23, 2026, are designated for general corporate purposes and working capital. This financial maneuver seeks to bolster the company's liquidity.